ALLEN MONTY K 4

What Happened

• Monty K. Allen, a director of IRADIMED Corp. (IRMD), sold 1,000 shares on February 13, 2026. The weighted average sale price reported was $100.26, for a total proceeds value of $100,256. This was a sale (not a purchase or award), which is often routine insider selling rather than a direct signal of company prospects.

Key Details

• Transaction date: 2026-02-13.
• Transaction type: Sale (reported as "open market or private sale"); executed in multiple trades at prices ranging from $100.00 to $100.26; weighted average price $100.26 (see footnote F1).
• Total shares disposed: 1,000; total proceeds reported: $100,256.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: F1 states the sale occurred in multiple trades at prices $100.00–$100.26 and that the reporting person will provide detailed trade-level information upon request.
• Filing timeliness: Report filed with period of report 2026-02-13; appears to be timely (no late-filing indication).

Context

• This report documents a straightforward sale of shares by a corporate director. The filing includes no indication of a 10b5-1 plan, option exercise, gift, or tax-withholding transaction. Sales by directors can be routine (portfolio diversification, liquidity needs, etc.); the filing itself does not explain the reason.